This week seems to be all about cyclodextrin.
Chris Kevil’s group (Gopi Krishna Kolluru et al.) from Louisiana State University discovered the Sugammadex (among other prodrugs) could serve as an H2S donor and support the treatment of covid patients. Amazing work!
